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The prognosis of tetralogy of Fallot (TOF) treated only with Blalock-Taussig shunt (BTS) operation is unclear. A woman with TOF
underwent classic BTS operation at 10 years of age. Despite nomedication, she delivered two children and worked without apparent
heart failure. At 72 years of age, she complained of dyspnea on exertion and leg edema. The cardiac angiogram revealed a well-
patent BTS and severely stenotic right ventricular outﬂow tract. Right heart catheterization showed adequately maintained
pulmonary blood ﬂow with slight pulmonary arterial hypertension. Her unexpected yet favorable outcome reaﬃrms the
importance of structural and functional self-adaptation even with cyanosis. If she had undergone a valve-sparing corrective
surgery in adolescence, much better quality of life and outcome could have been expected.
1. Introduction
Tetralogy of Fallot (TOF) is the most common cause of
cyanotic congenital heart disease, and Blalock-Taussig shunt
(BTS) operation is considered the ﬁrst-step management for
maintaining pulmonary blood ﬂow in TOF patients. Com-
plete transventricular repair of TOF is the standard surgical
treatment that should be performed in infancy or early
childhood [1]. Long-term survival has improved because it
is associated with lower operative mortality [2, 3]. However,
the prognosis of patients with TOF treated by only palliative
operation remains unclear. We describe a patient with TOF
treated by classic BTS operation who lived a productive life
without obvious symptoms in the long term.
2. Case Presentation
A woman with TOF underwent left classic BTS operation by
the late cardiac surgeon Professor Shigeru Sakakibara at the
Tokyo Women’s Medical College, Tokyo, Japan, in the
1950s when she was 10 years old. She stopped visiting the
hospital a few years postoperatively because she did not have
diﬃculty performing daily activities. Subsequently, she got
married at 25 years of age and gave birth to two children at
29 years of age without special gynecological care at a local
hospital. She kept working on a production line while raising
her children without experiencing symptoms of heart failure.
At 70 years of age, she was found to have a low oxygen
saturation during a health examination program, but she
did not seek hospital care. She developed dyspnea and leg
edema when she was 72 years old, and then diuretic was
started for a diagnosis of heart failure at a local clinic. When
she was referred to our hospital for further evaluation, her
symptoms of heart failure were comparable with the New
York Heart Association (NYHA) functional class III. Her
oxygen saturation was 88% on room air at rest. Her heart
examination revealed a continuous murmur (Levine III/VI)
and systolic ejection murmur (IV/VI) in the second right
sternal border. Laboratory data showed the following
values (reference ranges): hemoglobin level 15.7 g/dl, hemat-
ocrit 44.5%, platelet count 19.7× 104/μl, prothrombin time
11.4 seconds, 98.5%, D-dimer level 1.2μg/dl (<1.0μg/dl),
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creatinine level 1.35mg/dl (0.4–0.8mg/dl), and serum brain-
type natriuretic peptide level 210 pg/ml (<18.4 pg/ml). A
chest radiograph revealed a cardiothoracic ratio of 66%,
right-sided aortic arch, and prominently dilated PA without
pulmonary congestion (Figure 1(a)). The electrocardiogram
showed sinus rhythm with a prolonged PR interval and
ST-T segment abnormalities (Figure 1(b)). The echocardio-
gram showed a large ventricular septal defect with a
bidirectional, mainly left-to-right shunt, overriding the
aorta, right ventricular (RV) hypertrophy, and a stenotic
RV outﬂow tract with a peak velocity of 4.9m/s (Figure 2).
Left ventricular (LV) diastolic indices of echocardiogram
were as follows: peak E velocity 80 cm/s, E/A 0.72, septal
E′ velocity 4.1 cm/s, lateral E′ velocity 3.5 cm/s, and aver-
age E/E′ 21. Abnormal relaxation pattern of transmitral
ﬂow, low E′ velocity, and high E/E′ suggested the existence
of LV diastolic dysfunction. The cardiac magnetic resonance
imaging scan showed reduced RV ejection fraction (EF) of
28% and preserved LVEF of 60% with a LV end-diastolic
volume index of 103ml/m2 (Figures 2(e) and 2(f)). There
was no abnormality in the pulmonary valve (PV), and the
diameter of the PV annulus was 24mm. The catheter angio-
gram revealed a patent BTS and severe stenosis at the ostium
of the left PA (Figure 3). Right heart catheterization
showed a normal PA wedge pressure (systolic/diastolic/
mean pressure: 15/9/8mmHg), mildly elevated PA pres-
sure (systolic/diastolic/mean pressure: 35/20/30mmHg),
elevated RV systolic and end-diastolic pressure (135/
20mmHg), mean right atrial pressure (11mmHg), and sys-
tolic and end-diastolic LV pressure (149/23mmHg). The
pressure gradient between the PA and right ventricle was
117mmHg. Cardiac output calculated by the Fick principle
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Figure 1: Electrocardiography and the chest X-ray. (a) Electrocardiogram shows normal sinus rhythm at 75 beats/min with a prolonged PR
interval; negative T in leads II, III, and aVF; and ST depression in V1 and V4–6. (b) Chest radiograph reveals a cardiothoracic ratio of 66%,
right-sided aortic arch, and dilated pulmonary arteries.
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Figure 2: Transthoracic echocardiogram and cardiac magnetic resonance imaging (CMRI). (a) Parasternal long-axis view shows the
ventricular septal defect (VSD) (white arrow) and overriding of the aorta. (b) Color Doppler image in the long-axis view shows two shunts
through the VSD (white arrow). (c) Apical four-chamber view shows the hypertrophic right ventricle. (d) There is an RV outﬂow
obstruction with a peak velocity of 4.9m/s. (e) Analysis of CMRI reveals a normal RV end-diastolic volume (76ml), reduced RV ejection
fraction of 28%, and preserved left ventricular ejection fraction of 60%. (f) CMRI scan shows subvalvular pulmonary stenosis (yellow arrow).
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was 2.9 l/min, and pulmonary vascular resistance index was
5.95Wood units⋅m2. The brain’s magnetic resonance imag-
ing scan showed no signiﬁcant abnormalities. She started to
take diuretics and home oxygen inspiration therapies; her
heart failure symptom improved to NYHA II. Based on the
clinical and hemodynamic assessments and her age, we
decided not to perform radical operation.
3. Discussion
The patient was fortunate to have a patent right ventricular
outﬂow tract (RVOT) that allowed her to live for ten years
without surgery. The combination of the classic BTS at age
10 and the patent RVOT provided enough pulmonary blood
ﬂow to allow her to survive into her seventies. The use of the
left classic BTS in the setting of a right aortic arch created a
source of pulmonary blood ﬂow that could grow along with
her. Also, the RVOT must have grown along with her
somatic growth [4].
Previous reports in PubMed of unoperated TOF surviv-
ing over 70 years old are shown in Table 1 [5–15]. There
are rarely reported studies on long-term outcome about
patients with TOF treated by only palliative operation.
Prolonged survival of patients with uncorrected TOF is
often associated with a well-developed left ventricle, initially
mild pulmonary stenosis, or well-maintained pulmonary
blood ﬂow by such as systemic to pulmonary collaterals or
persistent patent ductus arteriosus. Furthermore, in our case,
there was no history of signiﬁcant organ dysfunction due to
hypoxia, and no major complication of adult patients with
uncorrected TOF such as brain abscess or infective endocar-
ditis. Compared to previous reports (Table 1), it is an
important thing that she gave birth to two children without
signiﬁcant symptoms of heart failure. In the case reported
by Sousa et al. [15], the patient gave birth to one child
without complications; however, her subpulmonary stenosis
was very mild (maximum gradient of 31mmHg) and her
pulmonary blood ﬂow was well maintained (Qp/Qs = 0 9).
In our case, appropriately adjusted pulmonary blood ﬂow
by BTS might enable her to give birth to two children safely.
This patient had favorable anatomy that allowed her to
live for a long time, but there was evidence of biventricular
dysfunction accompanied with elevated right and left ven-
tricular end-diastolic pressure. It might be caused by long-
term pressure overload and cyanotic state. Although the
diameter of the PV annulus was measured in her seventies,
the size of 24mm must have been acceptable for valve-
sparing corrective surgery [16–18]. If she had undergone a
valve-sparing corrective surgery in adolescence, much better
quality of life and outcome could have been expected.
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Figure 3: Catheter angiography. (a) Right ventriculogram shows subvalvular pulmonary stenosis (black arrow). (b) Aortogram shows a right-
sided aortic arch and patent Blalock-Taussig shunt. There is stenosis at the ostium of the left pulmonary artery (yellow arrow) and both
pulmonary artery aneurysms. Ao: Aorta; BT shunt; Blalock-Taussig shunt; lt.PA: left pulmonary artery; rt.PA: right pulmonary artery; RV:
right ventricle.
Table 1: Previous reports in PubMed of unoperated TOF surviving over 70 years old.
Number Author (year) Age Gender Symptom or reason of admission Other cardiac complications
1 Thomas et al. (1987) [5] 77 Male Dyspnea Ductus arteriosus, mitral regurgitation
2 Fernicola et al. (1993) [6] 74 Male Dyspnea Mitral prolapse
3 Ishida et al. (2001) [7] 71 Male Dyspnea None
4 Bielik et al. (2005) [8] 74 Male Syncope None
5 Tanaka et al. (2005) [9] 72 Female Dyspnea None
6 Yang et al. (2005) [10] 73 Male Dyspnea None
7 Alonso et al. (2007) [11] 86 Male Chest pain Coronary artery disease
8 Nieves et al. (2007) [12] 70 Female Dyspnea None
9 Stanescu et al. (2008) [13] 75 Male Dyspnea Quadricuspid aortic valve
10 Subhawoang et al. (2009) [14] 87 Female Cerebral infraction None
11 Sousa et al. (2013) [15] 72 Female Dyspnea Endocarditis
3Case Reports in Cardiology
4. Conclusion
This case shows that classical BTS has a potential of long-
term patency with good functional capacity. Appropriately
adjusted pulmonary blood ﬂow by BTS may cause long-
term survival and a productive life in patients with TOF.
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